Part No: AN017-HORIssued year: 2009File size: 1.36mbFile type: pdf
The purpose of this application note is to demonstrate the use of a fully automated solid phase extraction (SPE) and concentration system that provides fast sample preparation while improving the quality and consistency of results for the Total Petroleum Hydrocarbon (TPH) compounds from C10 to C40 as dictated by EPA Method 8015.
Part No: P185Issued year: 2018File size: 1.27mbFile type: pdf
US EPA method 625 is used to determine acidic, basic, and neutral semi-volatile organic compounds (SVOC) in municipal and industrial wastewater. Revision A of this method is applied to a total possible list of 364 compounds that include; polynuclear aromatic hydrocarbons, chlorinated hydrocarbons, pesticides, phthalate esters, organophosphate esters, nitrosamines, haloethers, aldehydes, ethers, ketones, anilines, pyridines, quinolones, aromatic nitro compounds, and phenols.
Part No: AN857Issued year: 2016File size: 2.29mbFile type: pdf
This application note describes a protocol for the extraction of 1,25 di-OH Vitamin D2 and 1,25 di-OH Vitamin D3 metabolites from serum using supported liquid extraction prior to LC-MS/MS detection.
A calibration range between 5 and 500 pg/mL is demonstrated using a starting volume of 0.25 mL of serum. Sensitivity is maximized through the use of a simple PTAD derivatization and formation of a methylamine complex.
The method can be easily automated using the Biotage Extrahera. Details of the automated procedure and data comparing manual and automated method performance are included.
Part No: Issued year: 2011File size: 0.16mbFile type: pdf
Molecularly Imprinted Polymers (MIPs) are highly cross-linked polymers with selective binding sites engineered to contain recognition elements in defined positions1. MIPs have been developed for a large variety of small molecules, peptides, carbohydrates and even proteins. The schematic 0of a MIP site.
Part No: P055Issued year: 2013File size: 0.7mbFile type: pdf
Free urinary cortisol levels can be an indicator of a variety of disorders, such as Cushing Syndrome. This poster presents a simple method for the extraction of cortisol from urine demonstrating good recoveries and low ion suppression. LC-MS/MS analysis was performed using a Waters 2795 Liquid Handling Unit coupled to a Quattro Ultima Pt triple quadrupole MS using electrospray ionization, operated in the MRM mode. Supported liquid extraction method development resulted in recoveries greater than 90% for cortisol spiked urine. Calibration curves constructed using this method from 25-2000 ng/mL, demonstrated excellent linearity with coefficients of determination greater than 0.99.
Cortisol, Stress, Cushin's Syndrome, SLE, Supported Liquid Extraction, SPE, LLEMSACL, San Diego, 2013
Part No: Issued year: 2004File size: 0.39mbFile type: pdf
•Metal-mediated [2 + 3] cycloaddition to coordinated nitriles
-- synthesis of new transition metal complexes
-- synthesis of new heterocycles
-- enantioselective synthesis of heterocycles
role of microwaves?
• Platinum-catalysed cycloisomerisation of alkynes
-- Synthesis of Taxol-like compounds
-- highly efficient and atom economic chemistry
role of microwaves?
Part No: AN061Issued year: 2012File size: 0.63mbFile type: pdf
Acetone is successfully used as solvent in normal-phase flash chromatography when used with an Isolera™ Spektra flash purification system. The new λ-All detection and baseline correction features provide compound detection at all wavelengths in the detector’s range while minimizing any baseline drift due to solvent UV absorption.
Part No: P186Issued year: 2018File size: 0.2mbFile type: pdf
With the growing popularity and use of mass-directed flash
chromatography to purify specific compounds, it is important to understand that the sample’s compounds may not be detected as expected (e.g. M+H or M-H ions) because they may fragment or form adducts in the mass detector. This is true with both synthetic and natural product research.
Part No: PPS410Issued year: 2015File size: 0.7mbFile type: pdf
User Case: Professor Roger Strömberg, Karolinska Institutet. One of Professor Strömberg’s projects at Karolinska Institutet
involves the synthesis of artificial nucleases and PNAzymes. In
2013, his research group acquired a Biotage® Initiator+ Alstra™
peptide synthesizer for making PNAs and peptides.
Part No: PPS409Issued year: 2015File size: 1.61mbFile type: pdf
RIKEN is Japan’s largest research organization with 3,400
researchers from more than 50 countries. The chemists in RIKEN’s
Sugiyama Laboratory use EVOLUTE® EXPRESS solid-phase extraction
plates from Biotage in the analysis of clinical trial samples
for pharmacokinetic studies.
Part No: PPS432Issued year: 2016File size: 0.4mbFile type: pdf
Customer Case: Hitachi, Ltd. Healthcare Innovation Center. Hitachi’s R&D group has developed a new method for analyzing pharmacodynamics in cultured cells, in a study aimed at improving the pass rate in clinical trials. Mr. Ryosuke Takahashi tells the story.
Part No: Issued year: 2013File size: 0.43mbFile type: pdf
User report: ISOLUTE SLE+. Shin Nippon Biomedical Laboratories, Ltd. use ISOLUTE® SLE+ to prepare biological samples for pharmacokinetic testing as part of a drug discovery and development program. We had the chance to speak with Mr. Mitsuhiko Kawabata and Ms. Akiko Toda of the pharmacokinetics group.
Part No: T82Issued year: 2009File size: 0.09mbFile type: pdf
Snip and Pour standards come in pre-measured Teflon tubes of 10 mL each. Each tube contains
20 mg of n-Hexadecane and Stearic Acid for a total concentration of 40 mg. Care must be taken
upon the introduction of the spiking solution to the sample bottle.
Part No: PPS406Issued year: 2015File size: 2.25mbFile type: pdf
Tokyo based PeptiDream Inc. is a company specializing in non-standard peptide therapeutics containing non-standard amino acids, and conducts research and development of new drug candidates. PeptiDream uses the peptide synthesizers Syro I and Biotage® Initiator+ Alstra™ for the synthesis of various kinds of peptides to support drug discovery and development.
Part No: AN049-HORIssued year: 2009File size: 0.74mbFile type: pdf
The DryVap® Concentrator System was intentionally designed to provide enhanced recoveries of semivolatile organic compounds, such as those found in EPA Method 8270. Its unique design of using an internal immersion heater vs. an external water bath, vacuum, and a sparge gas which is directed onto the surface of the solvent during the final stages of the evaporation process, allows the DryVap® System to achieve very good recoveries for a variety of tests.